Compound ID | 45
PXL150
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Staphylococcal surgical site infections |
| Propensity to select resistant mutants: | Yes |
| Description: | Synthetic compound |
| Institute where first reported: | Pergamum AB, Karolinska Institutet Science Park, Solna, Sweden |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.